BIO
Price
$243.98
Change
+$0.51 (+0.21%)
Updated
Jun 27 closing price
Capitalization
9.79B
25 days until earnings call
ILMN
Price
$94.79
Change
+$0.63 (+0.67%)
Updated
Jun 27 closing price
Capitalization
21.09B
39 days until earnings call
Interact to see
Advertisement

BIO vs ILMN

Header iconBIO vs ILMN Comparison
Open Charts BIO vs ILMNBanner chart's image
Bio-Rad Laboratories
Price$243.98
Change+$0.51 (+0.21%)
Volume$322.85K
Capitalization9.79B
Illumina
Price$94.79
Change+$0.63 (+0.67%)
Volume$3.84M
Capitalization21.09B
BIO vs ILMN Comparison Chart in %
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. ILMN commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Buy and ILMN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (BIO: $243.98 vs. ILMN: $94.79)
Brand notoriety: BIO: Not notable vs. ILMN: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIO: 84% vs. ILMN: 173%
Market capitalization -- BIO: $9.79B vs. ILMN: $21.09B
BIO [@Medical Specialties] is valued at $9.79B. ILMN’s [@Medical Specialties] market capitalization is $21.09B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileILMN’s FA Score has 0 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • ILMN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BIO and ILMN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 5 TA indicator(s) are bullish while ILMN’s TA Score has 3 bullish TA indicator(s).

  • BIO’s TA Score: 5 bullish, 2 bearish.
  • ILMN’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, BIO is a better buy in the short-term than ILMN.

Price Growth

BIO (@Medical Specialties) experienced а +3.06% price change this week, while ILMN (@Medical Specialties) price change was +4.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.14%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was -0.01%.

Reported Earning Dates

BIO is expected to report earnings on Jul 24, 2025.

ILMN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+1.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ILMN($21.1B) has a higher market cap than BIO($9.79B). ILMN has higher P/E ratio than BIO: ILMN (49.50) vs BIO (3.64). BIO YTD gains are higher at: -25.731 vs. ILMN (-29.065). ILMN has higher annual earnings (EBITDA): -608M vs. BIO (-654.76M). BIO has more cash in the bank: 1.61B vs. ILMN (1.05B). BIO has less debt than ILMN: BIO (1.41B) vs ILMN (2.26B). ILMN has higher revenues than BIO: ILMN (4.5B) vs BIO (2.67B).
BIOILMNBIO / ILMN
Capitalization9.79B21.1B46%
EBITDA-654.76M-608M108%
Gain YTD-25.731-29.06589%
P/E Ratio3.6449.507%
Revenue2.67B4.5B59%
Total Cash1.61B1.05B152%
Total Debt1.41B2.26B62%
FUNDAMENTALS RATINGS
BIO vs ILMN: Fundamental Ratings
BIO
ILMN
OUTLOOK RATING
1..100
2337
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9595
PRICE GROWTH RATING
1..100
6052
P/E GROWTH RATING
1..100
8494
SEASONALITY SCORE
1..100
n/a39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ILMN's Valuation (77) in the Biotechnology industry is in the same range as BIO (80) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to BIO’s over the last 12 months.

ILMN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BIO (100) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to BIO’s over the last 12 months.

ILMN's SMR Rating (95) in the Biotechnology industry is in the same range as BIO (95) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to BIO’s over the last 12 months.

ILMN's Price Growth Rating (52) in the Biotechnology industry is in the same range as BIO (60) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to BIO’s over the last 12 months.

BIO's P/E Growth Rating (84) in the Medical Specialties industry is in the same range as ILMN (94) in the Biotechnology industry. This means that BIO’s stock grew similarly to ILMN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOILMN
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
72%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
70%
Aroon
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ILMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MCN6.130.01
+0.16%
Madison Covered Call & Equity Strategy Fund
USDX25.660.03
+0.11%
SGI Enhanced Core ETF
KTBA21.65N/A
N/A
Structured Products Corp.
CRAK32.36N/A
N/A
VanEck Oil Refiners ETF
PGX11.10-0.05
-0.45%
Invesco Preferred ETF

BIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
+0.21%
A - BIO
70%
Closely correlated
-0.21%
TMO - BIO
70%
Closely correlated
-0.93%
DHR - BIO
67%
Closely correlated
-1.16%
MTD - BIO
66%
Loosely correlated
-0.73%
BRKR - BIO
65%
Loosely correlated
-0.90%
More

ILMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with A. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
+0.67%
A - ILMN
65%
Loosely correlated
-0.21%
RVTY - ILMN
64%
Loosely correlated
-0.98%
BIO - ILMN
63%
Loosely correlated
+0.21%
BRKR - ILMN
63%
Loosely correlated
-0.90%
MTD - ILMN
59%
Loosely correlated
-0.73%
More